aap Implantate AG (AAQ1.DE)
EUR 1.47
(19.51%)
EUR 1.47
(19.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.12 Million EUR | -99.88% |
| 2022 | -2.56 Million EUR | -1.67% |
| 2021 | -2.52 Million EUR | 71.78% |
| 2020 | -8.93 Million EUR | 54.03% |
| 2019 | -19.43 Million EUR | -153.57% |
| 2018 | -7.66 Million EUR | 17.31% |
| 2017 | -9.27 Million EUR | -163.37% |
| 2016 | 14.62 Million EUR | 376.44% |
| 2015 | -5.29 Million EUR | -1060.53% |
| 2014 | -456 Thousand EUR | 81.42% |
| 2013 | -2.45 Million EUR | -201.83% |
| 2012 | 2.41 Million EUR | 510.13% |
| 2011 | 395 Thousand EUR | 674.51% |
| 2010 | 51 Thousand EUR | -97.37% |
| 2009 | 1.93 Million EUR | 137.03% |
| 2008 | -5.23 Million EUR | -446.39% |
| 2007 | 1.51 Million EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 655 Thousand EUR | 568.98% |
| 2004 | -139.66 Thousand EUR | 99.09% |
| 2003 | -15.42 Million EUR | -241.19% |
| 2002 | -4.52 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -996.5 Thousand EUR | -145.14% |
| 2023 Q2 | -1.03 Million EUR | -3.56% |
| 2023 FY | -5.12 Million EUR | -99.88% |
| 2022 Q4 | -406.5 Thousand EUR | 0.0% |
| 2022 FY | -2.56 Million EUR | -1.67% |
| 2022 Q1 | -1.17 Million EUR | -87.13% |
| 2022 Q2 | -573 Thousand EUR | 51.36% |
| 2022 Q3 | -406.5 Thousand EUR | 29.06% |
| 2021 Q1 | -1.09 Million EUR | 21.61% |
| 2021 FY | -2.52 Million EUR | 71.78% |
| 2021 Q2 | -179 Thousand EUR | 83.58% |
| 2021 Q3 | -629.5 Thousand EUR | -251.68% |
| 2021 Q4 | -629.5 Thousand EUR | 0.0% |
| 2020 Q4 | -1.39 Million EUR | 0.0% |
| 2020 Q3 | -1.39 Million EUR | 63.43% |
| 2020 FY | -8.93 Million EUR | 54.03% |
| 2020 Q2 | -3.8 Million EUR | -61.51% |
| 2020 Q1 | -2.35 Million EUR | 68.66% |
| 2019 Q2 | -3.06 Million EUR | -127.26% |
| 2019 Q3 | -7.51 Million EUR | -144.8% |
| 2019 FY | -19.43 Million EUR | -153.57% |
| 2019 Q1 | -1.35 Million EUR | 38.61% |
| 2019 Q4 | -7.51 Million EUR | 0.0% |
| 2018 Q3 | -1.85 Million EUR | -34.99% |
| 2018 FY | -7.66 Million EUR | 17.31% |
| 2018 Q2 | -1.37 Million EUR | 38.86% |
| 2018 Q1 | -2.24 Million EUR | -4.52% |
| 2018 Q4 | -2.19 Million EUR | -18.74% |
| 2017 FY | -9.27 Million EUR | -163.37% |
| 2017 Q2 | -2.64 Million EUR | -21.87% |
| 2017 Q4 | -2.14 Million EUR | 7.3% |
| 2017 Q3 | -2.31 Million EUR | 12.31% |
| 2017 Q1 | -2.16 Million EUR | -3.78% |
| 2016 Q2 | 21.81 Million EUR | 1006.61% |
| 2016 Q1 | -2.4 Million EUR | 23.03% |
| 2016 FY | 14.62 Million EUR | 376.44% |
| 2016 Q4 | -2.08 Million EUR | 22.35% |
| 2016 Q3 | -2.68 Million EUR | -112.33% |
| 2015 Q2 | -1.49 Million EUR | -228.07% |
| 2015 Q3 | -214 Thousand EUR | 85.7% |
| 2015 Q4 | -3.12 Million EUR | -1360.75% |
| 2015 FY | -5.29 Million EUR | -1060.53% |
| 2015 Q1 | -456 Thousand EUR | 64.29% |
| 2014 Q2 | 940 Thousand EUR | 355.43% |
| 2014 FY | -456 Thousand EUR | 81.42% |
| 2014 Q4 | -1.27 Million EUR | -612.85% |
| 2014 Q3 | 249 Thousand EUR | -73.51% |
| 2014 Q1 | -368 Thousand EUR | 92.65% |
| 2013 Q4 | -5 Million EUR | -1920.36% |
| 2013 FY | -2.45 Million EUR | -201.83% |
| 2013 Q1 | 2.12 Million EUR | 242.65% |
| 2013 Q2 | 156 Thousand EUR | -92.64% |
| 2013 Q3 | 275 Thousand EUR | 76.28% |
| 2012 Q4 | 619 Thousand EUR | 118.73% |
| 2012 FY | 2.41 Million EUR | 510.13% |
| 2012 Q1 | 1.13 Million EUR | 321.85% |
| 2012 Q2 | 369 Thousand EUR | -67.6% |
| 2012 Q3 | 283 Thousand EUR | -23.31% |
| 2011 Q1 | -188 Thousand EUR | 64.46% |
| 2011 Q4 | 270 Thousand EUR | 364.71% |
| 2011 FY | 395 Thousand EUR | 674.51% |
| 2011 Q3 | -102 Thousand EUR | -124.46% |
| 2011 Q2 | 417 Thousand EUR | 321.81% |
| 2010 FY | 51 Thousand EUR | -97.37% |
| 2010 Q2 | 287 Thousand EUR | 149.74% |
| 2010 Q1 | -577 Thousand EUR | -222.25% |
| 2010 Q3 | 847 Thousand EUR | 195.12% |
| 2010 Q4 | -529 Thousand EUR | -162.46% |
| 2009 Q4 | 472 Thousand EUR | -81.45% |
| 2009 FY | 1.93 Million EUR | 137.03% |
| 2009 Q3 | 2.54 Million EUR | 441.61% |
| 2009 Q2 | -745 Thousand EUR | -123.05% |
| 2009 Q1 | -334 Thousand EUR | 0.0% |
| 2008 Q2 | 490 Thousand EUR | 0.0% |
| 2008 FY | -5.23 Million EUR | -446.39% |
| 2007 FY | 1.51 Million EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 655 Thousand EUR | 568.98% |
| 2004 FY | -139.66 Thousand EUR | 99.09% |
| 2003 FY | -15.42 Million EUR | -241.19% |
| 2002 FY | -4.52 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 104.641% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 104.641% |
| elexxion AG | -983.06 Thousand EUR | -421.326% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 26.3 Million EUR | 119.487% |
| Geratherm Medical AG | 1.11 Million EUR | 561.231% |
| Koninklijke Philips N.V. | -466 Million EUR | 98.9% |
| Stratec SE | 13.06 Million EUR | 139.221% |
| Siemens Healthineers AG | 1.94 Billion EUR | 100.264% |